Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its Covid-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
Now, researchers at the USC Viterbi School of Engineering, armed with artificial intelligence tools, can rate a movie’s content in a matter of seconds.
This experiment is a proving ground for a pivotal challenge in modern robotics: the ability to guarantee the safety and success of automated robots operating in novel environments.
As optimism about a coronavirus vaccine drives a shift away from technology shares, one such stock in India keeps rallying as market watchers bet its investments in startups will start to pay off.
The study, published in the Journal of Physics: Complexity, used traffic speeds from taxis in New York City to demonstrate how road infrastructure and driver behavior can create complex road networks that differ among cities.
We will all suffer if the ‘free market economy’ decides who gets Covid-19 vaccine | Barbara Mintzes for The Conversation
As the world continues to grapple with Covid-19, the prospect of a vaccine gives us hope of returning to some kind of “normal” in the not-too-distant future.
Bill Gates expressed optimism about the potential effectiveness of COVID-19 vaccine candidates, pointing to evidence from Pfizer’s trial suggesting that only a “modest level of antibodies” will be required to protect people from contracting the virus.
Illegal business has exploded amid COVID-19 pandemic
A total of 3,073 trains passed through Manzhouli, an important channel for international cargo in north China’s Inner Mongolia Autonomous Region, between Jan. 1 and Nov. 17, marking a yearly increase of 30.3 percent.
A number of major South Korean pharmaceutical companies have recently signed a series of deals to manufacture vaccines and treatment drugs for the novel coronavirus, industry watchers said Wednesday.